PSI Journal Club: Missing Data

PSI Training Course: Effective Leadership – the keys to growing your leadership capabilities

This course will consist of three online half-day workshops. The first will be aimed at building trust, the backbone of leadership and a key to becoming effective. This is key to building a solid foundation. The second will be on improving communication as a technical leader. This workshop will focus on communication strategies for different stakeholders and will involve tips on effective communication and how to develop the skills of active listening, coaching and what improv can teach us about good communication. The final workshop will bring these two components together to help leaders become more influential. This will also focus on how to use Steven Covey’s 7-Habits, in particular Habits 4, 5 and 6, which are called the habits of communication. The workshops will be interactive, allowing you to practice the concepts discussed. There will be plenty of time for questions and discussion. There will also be reflective time where you can think about what you are learning and how you might experiment with it.

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q1 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Inclusive and Impactful Conference Contributions

This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

Strategic role of statisticians for JCA

Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.

Statisticians in the Age of AI: On Route to Strategic Partnership

A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Biography
Kevin Ding, Ocular Therapeutix	Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA	Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London	Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.

Speaker	Biography
Kevin Ding, Ocular Therapeutix	Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA	Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London	Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.

Speaker	Biography
Kevin Ding, Ocular Therapeutix	Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA	Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London	Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.

Speaker	Biography
Kevin Ding, Ocular Therapeutix	Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA	Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London	Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.

Speaker	Biography
Kevin Ding, Ocular Therapeutix	Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA	Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London	Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.

Past PSI Events

On this page:

Conferences